Management of Chronic Myeloid Leukemia by Advanced Practice Nurses

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the role of Advanced Practice Nurses (APNs) in managing patients with Chronic Myeloid Leukemia (CML) during the chronic phase. It focuses on optimizing treatment by addressing adverse events, ensuring treatment compliance, and assessing the quality of life of patients. The study aims to improve early detection of adverse events, which are often underreported, thereby enhancing patient care and therapeutic outcomes. Participants will receive both medical management and follow-up care from APNs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years old.
* CML patient in chronic phase, eligible for oral therapy.
* Newly diagnosed CML and/or initiating oral therapy :

  * Patient changing treatment for non-response or loss of therapeutic response or toxicities, on the condition that these toxicities are resolved or grade I maximum at the time of inclusion.
  * Newly start of oral therapy.
* Patient eligible to a follow-up by an advanced practice nurse.
* Patient capable to understand french and complete a questionnaire.

Exclusion Criteria:

* Patient that had a follow-up \> 3 months by an advanced practice nurse for CML before inclusion.
* Patient changing treatment for toxicities, if these toxicities are still \> grade I at inclusion.
* Patient enrolled in another interventional research protocol for CML.
* Pregnant women.
* Patient under legal protection, deprived of liberty or unable to be included in a research protocol.

Where it's running

• Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
  Avignon, France Recruiting

Study contacts

• Principal investigator: Christine Tosello, APN — Centre Hospitalier d'Avignon, Service d'Oncologie Médicale-Hématologie Clinique
• Study coordinator: Marilyne Grinand, PhD
• Email: grinand.marilyne@ch-avignon.fr
• Phone: (+33)432759392

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Real‑world CML patient registry looks at experiences and outcomes with first- or second-line TKI therapy

  This registry follows adults with chronic-phase CML who are on approved TKIs to see how they tolerate treatment, how safe it is, how well it works, and how patients feel over up to five years.

  Recruiting at 17 sites Novartis · Birmingham, Alabama and 16 other locations · NCT07091019

• Targeted T-Cell and B-Cell Depletion for Hematologic Malignancies

  This study is testing a new way to prepare patients with blood cancers for stem cell transplants by removing certain immune cells to see if it helps them recover better and stay healthy longer.

  Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT05794880

• Ultrasound try to predict macrosomia at term

  This study tests how well ultrasound weight estimates predict a baby’s birth weight in pregnancies with suspected macrosomia.

  Recruiting Centre Hospitalier Henri Duffaut - Avignon · Avignon · NCT07433751

• Osteopathic care for heart rate variability in advanced lung cancer patients

  This pilot test checks whether osteopathic manipulation can influence heart rate variability in people with stage 4 lung cancer who are receiving chemotherapy.

  Recruiting Centre Hospitalier Henri Duffaut - Avignon · Avignon · NCT06822348

• Prehabilitation using adapted physical activity for multiple myeloma patients before autologous stem cell transplant

  This tests whether a prehabilitation program of adapted physical activity can help adults with multiple myeloma preparing for autologous stem cell transplant reduce fatigue and improve quality of life.

  Recruiting Centre Hospitalier Henri Duffaut - Avignon · Avignon · NCT06789003

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.